4CRF
Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | ROTATING ANODE |
| Source details | RIGAKU FR-E+ |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2010-05-11 |
| Detector | RIGAKU SATURN A200 |
| Spacegroup name | I 2 3 |
| Unit cell lengths | 120.990, 120.990, 120.990 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 32.400 - 2.300 |
| R-factor | 0.184 |
| Rwork | 0.181 |
| R-free | 0.24400 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Data reduction software | MOSFLM |
| Data scaling software | SCALA |
| Phasing software | MOLREP |
| Refinement software | REFMAC (5.7.0029) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 32.400 | 2.360 |
| High resolution limit [Å] | 2.300 | 2.300 |
| Rmerge | 0.227 | 1.120 |
| Number of reflections | 13350 | |
| <I/σ(I)> | 9.5 | 2.1 |
| Completeness [%] | 100.0 | 100 |
| Redundancy | 9.9 | 9.5 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 8.5 | 2M AMMONIUM SULFATE, 0.1M TRIS-CL PH 8.5, 0.2M NACL |
